Table: Immuno Biological Lab -2021/22 group results

Immuno-Biological Laboratories

13/05/2022 07:30

May 13 (Reuters)- 
          Immuno Biological Laboratories Co Ltd 
          CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended      Year ended        Year to        NEXT   
              Mar 31, 2022    Mar 31, 2021    Mar 31, 2023      YEAR     
                 LATEST         YEAR-AGO         COMPANY       COMPANY   
                 RESULTS         RESULTS        FORECAST     H1 FORECAST 
  Sales          647 mln         602 mln         775 mln                 
               (+7.4 pct)      (+4.5 pct)      (+19.7 pct)               
  Operating   loss 122 mln    loss 240 mln        3 mln                  
  Recurring   loss 243 mln    loss 310 mln     loss 95 mln               
  Net
  Net         loss 258 mln    loss 318 mln    loss 120 mln               
  EPS        loss 27.78 yen  loss 34.23 yen  loss 12.88 yen              
  Ann Div          NIL             NIL             NIL                   
  -Q2 Div          NIL             NIL             NIL                   
  -Q4 Div          NIL             NIL             NIL                   
  
  NOTE - Immuno Biological Laboratories Co Ltd.
  *Second Net profit row denotes profit attributable to owners ofthe parent 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4570.T